![](/img/cover-not-exists.png)
Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine
Fukuda, Takayo, Tanabe, Masahiko, Kobayashi, Kokoro, Fukada, Ippei, Takahashi, Shunji, Iwase, Takuji, Ito, YoshinoriVolume:
4
Language:
english
Journal:
SpringerPlus
DOI:
10.1186/s40064-015-1159-4
Date:
December, 2015
File:
PDF, 783 KB
english, 2015